VSTM
Verastem IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$497.19M
P/E Ratio
—
EPS
$-3.02
Beta
0.43
52W High
$11.25
52W Low
$4.01
50-Day MA
$5.80
200-Day MA
$7.40
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
-1.89
About Verastem Inc
Verastem, Inc., a developing-stage biopharmaceutical company focused on developing and commercializing life-enhancing drugs for cancer patients. The company is headquartered in Needham, Massachusetts.
Fundamentals
| Revenue (TTM) | $30.91M |
| Gross Profit (TTM) | $26.31M |
| EBITDA | $-169.40M |
| Operating Margin | -236.50% |
| Return on Equity | -1480.00% |
| Return on Assets | -61.10% |
| Revenue/Share (TTM) | $0.45 |
| Book Value | $0.74 |
| Price-to-Book | 8.16 |
| Price-to-Sales (TTM) | 16.08 |
| EV/Revenue | 10.99 |
| EV/EBITDA | -0.19 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -78.60% |
| Shares Outstanding | $87.84M |
| Float | $75.07M |
| % Insiders | 0.76% |
| % Institutions | 87.59% |
Historical Volatility
HV 10-Day
71.88%
HV 20-Day
73.10%
HV 30-Day
67.74%
HV 60-Day
65.00%
HV Rank
28.2%
Volatility is currently expanding
Analyst Ratings
Consensus ($16.38 target)
1
Strong Buy8
BuyData last updated: 4/14/2026